Syneron to Acquire Ultrashape

by Benzinga Staff
February 8, 2012 9:00 AM | 20 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Syneron Medical Ltd.(NASDAQ: ELOS), announced today that is has signed a definitive agreement to acquireUltrashape Ltd, a leading developer, manufacturer andmarketer of innovative non-invasive technologies for fat celldestruction and body sculpting. Ultrashape is the sole operatingentity of Ultrashape Medical Ltd. and it owns all rightsand interests in the fat cell reduction and body sculpting business.Ultrashape's products are approved and commercially available inEurope, Canada, Latin America and Asia.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsM&A

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.